ALPHARETTA, Ga. , Feb. 21, 2024 /PRNewswire/ -- In direct response to the Nurse Assist, LLC voluntary recall of pre-filled syringes and other sterile water products, Avanos Medical, Inc. (NYSE: AVNS) voluntarily recalled specific lots of MIC* Gastric – Jejunal Feeding Tube Kits on Jan. 16, 2024 . These kits include Nurse Assist supplied syringes, pre-filled with sterile water, essential for inflating the retention balloon of... Read More

ALPHARETTA, Ga. , Feb. 20, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2023 results. "We were very pleased with the overall execution on our transformation initiative last year, which sets the foundation for more profitable growth in 2024 and for reaching our mid-term financial targets in 2025," said Joe Woody , Avanos's chief executive officer. Woody continued, "We... Read More

ALPHARETTA, Ga. , Feb. 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2023 on Tuesday, Feb. 20 at 9 a.m., ET . The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody , chief executive officer, and... Read More

ALPHARETTA, Ga. , Jan. 4, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported selected, unaudited preliminary financial results for the fourth quarter and full-year ended December 31, 2023 and revised its preliminary revenue outlook for 2024. Preliminary Unaudited Financial Results For the fourth quarter ended December 31, 2023 , Avanos Medical, Inc. (the "Company") expects net sales in the range of $170... Read More

ALPHARETTA, Ga. , Jan. 2, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 42 nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, Jan. 8 at approximately 3:45 p.m., PST. A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that... Read More

ALPHARETTA, Ga. , Nov. 7, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner , senior vice president, chief financial officer, and chief transformation officer, will participate in an analyst-led fireside chat at the Stifel 2023 Healthcare Conference on Tuesday, Nov. 14 at approximately 10:20 a.m. ET . A webcast of the conference presentation... Read More

Strong Free Cash Flow Generation in Excess of $25 Million ALPHARETTA, Ga. , Nov. 1, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2023 financial results. "We are pleased with our results for this quarter as we continue to deliver above-market growth in our Digestive Health markets," said Joe Woody , Avanos's chief executive officer. Woody continued, "We believe we are poised to sustain... Read More

ALPHARETTA, Ga. , Oct. 25, 2023 /PRNewswire/ -- Avanos Medical, Inc. ( NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2023 on Wednesday, Nov. 1 at 9 a.m., ET . The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody , chief executive officer, and Michael Greiner ,... Read More

ALPHARETTA, Ga. , Sept. 12, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King's virtual 21 st Annual Best Ideas Conference 2023 on Mon., Sept. 18 at approximately 8:45 a.m. Eastern Time. A webcast of the conference presentation will be available on the... Read More

ALPHARETTA, Ga. , Aug. 9, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2023 financial results. "We posted solid second quarter earnings, with Digestive Health continuing to deliver above-market growth and expanded margins," stated Joe Woody , Avanos's chief executive officer. Woody continued, "Separately, we continue to deliver on our transformation priorities and remain highly focused... Read More

ALPHARETTA, Ga. , Aug. 8, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at the UBS MedTech, Tools and Genomics Summit 2023 on Tues., Aug. 15 at approximately 1:00 p.m. Pacific Time. A webcast of the conference presentation will be available on the Investors... Read More

ALPHARETTA, Ga. , Aug. 2, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2023 on Wednesday, Aug. 9 at 9 a.m., ET . The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody , chief executive officer, and Michael Greiner ,... Read More

New guidance supports use of radiofrequency ablation for osteoarthritic knee pain ALPHARETTA, Ga. , June 28, 2023 /PRNewswire/ -- Avanos Medical supports the announcement today from the UK's National Institute for Health and Care Excellence (NICE) recommending the use of radiofrequency ablation (RFA) for the treatment of osteoarthritic knee pain. From the NICE announcement: "Radiofrequency energy is used to denervate the... Read More

Unique tined-probe technology further differentiates Avanos portfolio ALPHARETTA, Ga. , June 19, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to acquire Diros Technology Inc., a leading manufacturer of innovative radiofrequency (RF) products used to treat chronic pain conditions. Based in Toronto, Canada , Diros Technology has been at the forefront of... Read More

ALPHARETTA, Ga. , June 13, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it will host an Investor Day at Convene on 101 Park Avenue, New York , on Tuesday, June 20th, 2023 . Chief Executive Officer Joe Woody , and SVP, Chief Financial Officer and Chief Transformation Officer, Michael Greiner , along with key members of Avanos' senior management team, will discuss the company's commercial... Read More

ALPHARETTA, Ga. , June 8, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced it has entered into a definitive agreement to sell its Respiratory Health (RH) business to SunMed Group Holdings, LLC (SunMed). Headquartered in Grand Rapids, Michigan , SunMed is a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care with a comprehensive product... Read More

ALPHARETTA, Ga. , May 3, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2023 financial results. "Our first quarter results were mixed, with our digestive health portfolio continuing to outperform, strong adjusted earnings per share and continued margin improvement partially offset by our results in our pain portfolio," stated Joe Woody , Avanos's chief executive officer. Woody continued,... Read More

ALPHARETTA, Ga. , April 26, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2023 on Wednesday, May 3 at 9 a.m., ET . The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody , chief executive officer, and Michael Greiner ,... Read More

ALPHARETTA, Ga. , March 15, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer and chief transformation officer, will present and participate in an analyst-led fireside chat at the 2023 virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Wed., March 22 at approximately 9:45 a.m., ET. A webcast of the conference... Read More

ALPHARETTA, Ga. , March 6, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dr. Lisa Egbuonu-Davis , currently vice president, medical innovations, for DH Diagnostics, LLC, an affiliate of Danaher Corporation, has been appointed as a new independent member of the Avanos board of directors and will serve as a member of the compliance and governance committees. "We are pleased and excited to welcome... Read More

ALPHARETTA, Ga. , Jan. 11, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced two executive leadership appointments that support the company's long-term strategic priorities: Michael Greiner has been named chief transformation officer (in addition to his current responsibilities as senior vice president and chief financial officer), and Kerr Holbrook has been named senior vice president and chief... Read More

ALPHARETTA, Ga. , Jan. 4, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California on Wednesday, Jan. 11 at approximately 4:30 p.m., PST. A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on... Read More